VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ALNY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ALNYAlnylam Pharmaceuticals, Inc.
$321.59$42.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksALNYQuarterly Financials

Alnylam Pharmaceuticals, Inc. (ALNY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Alnylam Pharmaceuticals, Inc. (ALNY) quarterly income statement — complete revenue, gross profit & net income history

ALNY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue1.17B1.1B1.25B773.69M594.19M593.17M500.92M659.83M494.33M439.72M750.53M318.75M319.29M335.04M264.31M224.82M213.26M258.54M187.63M220.55M
Revenue Growth %96.43%84.95%149.35%17.26%20.2%34.9%-33.26%107%54.82%31.25%183.96%41.78%49.72%29.59%40.86%1.93%20.1%58.07%49.09%112.15%
Cost of Goods Sold211.12M267.72M197.23M142.95M71.04M102.82M85.91M68.67M65.98M85.86M84.31M85.37M54.87M51.27M41.12M40.81M35.63M37.66M32.66M38.76M
COGS % of Revenue18.09%24.4%15.79%18.48%11.96%17.33%17.15%10.41%13.35%19.53%11.23%26.78%17.18%15.3%15.56%18.15%16.71%14.57%17.41%17.57%
Gross Profit956.05M829.31M1.05B630.74M523.15M490.35M415.01M591.15M428.36M353.86M666.22M233.38M264.42M283.77M223.19M184.01M177.63M220.87M154.97M181.8M
Gross Margin %81.91%75.6%84.21%81.52%88.04%82.67%82.85%89.59%86.65%80.47%88.77%73.22%82.82%84.7%84.44%81.85%83.29%85.43%82.59%82.43%
Gross Profit Growth %82.75%69.13%153.44%6.7%22.13%38.57%-37.71%153.3%62%24.7%198.5%26.83%48.86%28.48%44.02%1.22%21.25%57.16%48.93%116.34%
Operating Expenses687.42M697.59M683.81M646.93M505.07M595.51M491.92M542.54M471.79M470.26M452.35M463.21M414.23M472.38M481.23M375.7M324.36M415.43M336.65M327.96M
OpEx % of Revenue58.9%63.59%54.75%83.62%85%100.39%98.2%82.22%95.44%106.95%60.27%145.32%129.73%141%182.07%167.11%152.1%160.69%179.42%148.7%
Selling, General & Admin322.55M325.37M322.08M323.31M239.95M295.34M220.99M248.4M210.8M198.12M199.18M214.69M183.66M210.34M235.86M169.98M154.47M186.38M142.07M145.32M
SG&A % of Revenue27.64%29.66%25.79%41.79%40.38%49.79%44.12%37.65%42.64%45.06%26.54%67.35%57.52%62.78%89.24%75.61%72.43%72.09%75.72%65.89%
Research & Development364.87M372.22M358.81M323.62M265.12M300.17M270.93M294.14M261M272.14M253.18M248.53M230.57M262.04M245.37M205.71M169.89M229.05M194.57M182.63M
R&D % of Revenue31.26%33.93%28.73%41.83%44.62%50.6%54.09%44.58%52.8%61.89%33.73%77.97%72.21%78.21%92.84%91.5%79.67%88.6%103.7%82.81%
Other Operating Expenses001000K0000000000000000-140K
Operating Income268.64M131.72M367.98M-16.2M18.08M-105.16M-76.91M48.61M-43.44M-116.4M213.87M-229.83M-149.81M-188.61M-258.04M-191.69M-146.73M-194.56M-181.68M-146.16M
Operating Margin %23.02%12.01%29.46%-2.09%3.04%-17.73%-15.35%7.37%-8.79%-26.47%28.5%-72.1%-46.92%-56.3%-97.63%-85.26%-68.8%-75.26%-96.83%-66.27%
Operating Income Growth %1386.07%225.26%578.49%-133.32%141.62%9.66%-135.96%121.15%71.01%38.28%182.88%-19.9%-2.1%3.06%-42.03%-31.15%21.22%-0.17%19.33%26.5%
EBITDA152.37M145.22M381.79M-2.25M32.48M-90.99M-62.92M63.62M-29.92M-102.92M227.19M-216.65M-135.74M-174.3M-247.44M-181.59M-137.27M-183.19M-169.89M-134.35M
EBITDA Margin %13.05%13.24%30.57%-0.29%5.47%-15.34%-12.56%9.64%-6.05%-23.41%30.27%-67.97%-42.51%-52.03%-93.62%-80.77%-64.37%-70.86%-90.54%-60.92%
EBITDA Growth %369.08%259.6%706.75%-103.54%208.57%11.59%-127.7%129.36%77.96%40.95%191.82%-19.31%1.11%4.85%-45.65%-35.16%20.95%0.35%21.57%29.53%
D&A (Non-Cash Add-back)013.51M13.8M13.94M14.4M14.17M13.98M15M13.52M13.48M13.33M13.18M14.06M14.31M10.6M10.1M9.46M11.38M11.79M11.8M
EBIT152.37M131.72M283.37M4.89M-2.95M-154.99M-74.29M22.09M-28.33M-106.35M181.63M-244.17M-143.41M-177.11M-364.86M-232.06M-196.99M-223.49M-163.96M-154.91M
Net Interest Income-42.69M-102.71M-15.72M-12.76M-9.97M-7.95M-2.23M-4.08M-5.61M-932K-5.47M-8.96M-10.3M-15.84M-33.26M-40.71M-41.35M-36.32M-40.05M-33.01M
Interest Income26.6M26.63M28.68M27.49M28.67M31.02M32.15M29.18M29.64M30.41M25.43M21.07M18.66M14.08M7.82M1.9M1.01M495K225K409K
Interest Expense69.29M129.34M44.4M40.25M38.65M38.97M34.38M33.26M35.25M31.34M30.89M30.04M28.95M29.91M41.08M42.61M42.36M36.82M40.27M33.42M
Other Income/Expense-46.98M29.42M-129.01M-19.16M-59.67M-88.8M-31.76M-59.78M-20.15M-21.28M-63.13M-44.38M-22.55M-18.41M-147.9M-82.99M-92.62M-65.74M-22.56M-42.17M
Pretax Income221.65M161.14M238.97M-35.36M-41.6M-193.96M-108.66M-11.17M-63.59M-137.69M150.74M-274.21M-172.36M-207.02M-405.94M-274.67M-239.36M-260.3M-204.24M-188.33M
Pretax Margin %18.99%14.69%19.13%-4.57%-7%-32.7%-21.69%-1.69%-12.86%-31.31%20.08%-86.03%-53.98%-61.79%-153.59%-122.18%-112.24%-100.68%-108.85%-85.39%
Income Tax-15.66M-25.28M-12.12M30.92M15.88M-110.19M2.91M5.72M2.35M183K2.99M1.81M1.74M472K-23K2.73M985K-1.84M278K1.23M
Effective Tax Rate %-7.07%-15.69%-5.07%-87.45%-38.18%56.81%-2.68%-51.24%-3.69%-0.13%1.98%-0.66%-1.01%-0.23%0.01%-0.99%-0.41%0.71%-0.14%-0.65%
Net Income205.99M186.42M251.08M-66.28M-57.48M-83.76M-111.57M-16.89M-65.94M-137.87M147.75M-276.02M-174.1M-207.49M-405.92M-277.4M-240.34M-258.46M-204.51M-189.56M
Net Margin %17.65%16.99%20.1%-8.57%-9.67%-14.12%-22.27%-2.56%-13.34%-31.35%19.69%-86.59%-54.53%-61.93%-153.58%-123.39%-112.7%-99.97%-109%-85.95%
Net Income Growth %458.38%322.56%325.05%-292.43%12.82%39.24%-175.51%93.88%62.13%33.55%136.4%0.5%27.56%19.72%-98.48%-46.34%-20%-6.13%19.26%-5.76%
Net Income (Continuing)237.31M186.42M251.08M-66.28M-57.48M-83.76M-111.57M-16.89M-65.94M-137.87M147.75M-276.02M-174.1M-207.49M-405.92M-277.4M-240.34M-258.46M-204.51M-189.56M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.511.371.84-0.51-0.44-0.65-0.87-0.13-0.52-1.101.15-2.21-1.40-1.68-3.32-2.29-2.00-2.16-1.72-1.61
EPS Growth %443.18%310.77%311.49%-292.31%15.38%40.91%-175.65%94.12%62.86%34.52%134.64%3.49%30%22.22%-93.02%-42.24%-16.96%-3.35%21.1%-3.21%
EPS (Basic)1.551.411.91-0.51-0.44-0.65-0.87-0.13-0.52-1.101.18-2.21-1.40-1.68-3.32-2.29-2.00-2.16-1.72-1.61
Diluted Shares Outstanding138.23M136.28M137.35M129.68M129.68M128.59M128.59M126.73M126.14M125.61M131.34M124.66M124.11M123.27M122.17M120.9M120.39M119.77M119.14M117.77M
Basic Shares Outstanding132.89M132.23M131.45M129.68M129.68M128.59M128.59M126.73M126.14M125.61M125.22M124.66M124.11M123.27M122.17M120.9M120.17M119.77M118.9M117.77M
Dividend Payout Ratio--------------------